Horwood, C. http://orcid.org/0000-0003-4395-1423
Haskins, L.
Mapumulo, S.
Connolly, C.
Luthuli, S.
Jensen, C.
Pansegrouw, D.
McKerrow, N.
Funding for this research was provided by:
ELMA Foundation (19-F0009/UKZN/ELMA, 19-F0009/UKZN/ELMA, 19-F0009/UKZN/ELMA, 19-F0009/UKZN/ELMA, 19-F0009/UKZN/ELMA, 19-F0009/UKZN/ELMA)
Article History
Received: 28 March 2023
Accepted: 2 January 2024
First Online: 8 February 2024
Declarations
:
: Ethical approval was obtained from the Biomedical Research Ethics Committee at the University of KwaZulu-Natal (BFC 157/19) and the KwaZulu-Natal Department of Health (KZ_201907_001). All participants provided written informed consent to participate. To ensure anonymity, participants and clinics were allocated a study number and no identifying information was collected. Mothers of all eligible children provided written informed consent after exiting the consulting room. Mothers were assured of confidentiality and informed that they were free to refuse to participate at any time without affecting their child’s care. When records were scanned all personal information was covered. To ensure children received all required medications, the IMCI expert dispensed any medication omitted by the participant. Any child requiring urgent referral identified by the IMCI expert was provided with pre-referral treatment and referred urgently. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.